Pulmonary Arterial Hypertension Key Players – Arena Pharmaceuticals Bayer, Eiger BioPharmaceuticals, Gilead and Merck Market Analysis & Forecast to 2026
Pulmonary Arterial HypertensionOverview
Pulmonary arterial hypertension (PAH) is a rare, fatal cardiopulmonary disease with an annual mortality rate of 15%. The disease is a subset (Group 1) within the World Health Organization’s (WHO’s) classification of the different types of pulmonary hypertension (PH). PAH is characterized by an abnormal rise in the resting mean pulmonary arterial pressure (>25mmHg compared with normal levels of around 14mmHg. ). This increased pressure is caused by pulmonary arterial obstruction due to endothelial dysfunction and vascular remodeling, and leads to increased resistance in the arterial blood vessels
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2775734-opportunityanalyzer-pulmonary-arterial-hypertension-opportunity-analysis-and-forecasts-to-2026
Top Companies mentioned
Actelion Pharmaceuticals (now key subsidiary of Johnson & Johnson)
Arena Pharmaceuticals Bayer
Eiger BioPharmaceuticals
Eli Lilly
Gilead
GlaxoSmithKline
Merck
Mochida Pharmaceutical
Nippon Shinyaku Co. Ltd
Major Highlight
Since PAH is a progressive disorder, the pulmonary pressure keeps building up as the patient advances through the later stages of the disease, leading to reduced cardiac output, right heart failure, and ultimately, death.
The 5EU market is anticipated to grow the fastest of the three regions, recording a CAGR of 5.4%, while the US and Japan will each record CAGRs of 1.2% and 1.0%, respectively. At the end of 2026, the US will contribute around 67% of global sales, while the 5EU and Japan will account for 28% and 5% of global sales, respectively.
The higher sales numbers for the US can be attributed to the higher price of pharmaceuticals and the greater diagnosed prevalence of PAH in the region.
Scope
Overview of pulmonary arterial hypertension, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
Annualized PAH therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2016 and forecast for ten years to 2026.
Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the PAH therapeutics market.
Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.
Analysis of the current and future market competition in the global PAH therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2775734-opportunityanalyzer-pulmonary-arterial-hypertension-opportunity-analysis-and-forecasts-to-2026
Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.
WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Arterial Hypertension Key Players – Arena Pharmaceuticals Bayer, Eiger BioPharmaceuticals, Gilead and Merck Market Analysis & Forecast to 2026 here
News-ID: 959332 • Views: …
More Releases from WiseGuy Research consultants Pvt Ltd.
Beauty Drinks Market and its Future Outlook and Trend During the Period of 2019 …
Global Beauty Drinks Market Research Report 2019
Summary: -
Wiseguyreports.Com Adds “Beauty Drinks - Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2025” To Its Research Database.
Overview:
Beauty drinks refer to both carbonated and non-carbonated beverages, which is used to retain natural beauty during aging. The beauty drinks contain various vitamins, minerals, amino acids, and antioxidants. It aids to support diets by encouraging metabolism. The global beauty drinks market…
Global Capsule Endoscopy Treatment Solutions Market 2020: key Vendors, Trends, A …
Summary
A New Market Study, titled “Capsule Endoscopy Treatment Solutions Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.
This report provides in depth study of “Capsule Endoscopy Treatment Solutions Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Capsule Endoscopy Treatment Solutions Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such…
Data Center Colocation Market 2019: Size, Share, Demand, Trends, Growth and 2025 …
Global Data Center Colocation Industry
New Study On “2019-2025 Data Center Colocation Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database
Data center operators face an increasing need for scalable data center infrastructure, which enables the scaling of critical data center components as and when the demand increases. The data center colocation provides data center space, along with the power and cooling infrastructure, which address…
Temperature Logger Market 2019 Trends, Research, Analysis & Review Forecast 2025
Global Temperature Logger Industry
New Study On “2019-2025 Temperature Logger Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database
This report studies the global Temperature Logger market status and forecast, categorizes the global Temperature Logger market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The…
More Releases for PAH
Development: Pulmonary Arterial Hypertension (PAH) Market Growth Analysis
The global pulmonary arterial hypertension (pah) market is estimated to surpass $9,670.2 million by 2027, exhibiting a CAGR of 5.8% from 2020 to 2027.
The report provides all-inclusive analysis of global pulmonary arterial hypertension (pah) market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.
Research Methodology
Research Dive offers its clients extensive research and analysis gleaned from wide…
Pulmonary Arterial Hypertension (PAH) Market Research and Clinical Analysis 2020
Global Pulmonary Arterial Hypertension (PAH) Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters.
This Pulmonary Arterial Hypertension (PAH) Market research report identifies the competitive landscape of industries to understand the competition at International level.…
Pulmonary Arterial Hypertension (PAH) Medicine Market (2020-2027) Report Offers …
The research study includes the latest updates about the COVID-19 impact on the Pulmonary Arterial Hypertension (PAH) Medicine sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.
The market research report on the global Pulmonary Arterial Hypertension (PAH) Medicine market provides an extensive and…
Pulmonary Arterial Hypertension (PAH) - Market Outlook and Competitive Landscape …
Report Overview
The report provides a comprehensive view of disease events, types, severity, progression, symptoms, risk factors, pathogenesis and treatment guidelines at country level
Comprehensive insight on patient segmentation has been provided into the epidemiology of the Pulmonary Arterial Hypertension (PAH) and its treatment in the 8 MM countries, covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan, and China
Drug utilization and analysis on the current…
Global Pulmonary Arterial Hypertension (PAH) Market| MarketResearchReports.biz
Latest industry research report on: Global Pulmonary Arterial Hypertension (PAH) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of the global Pulmonary Arterial Hypertension (PAH) market on the basis of Drug Class (Endothelin Receptor Antagonists, Prostacyclin, Prostacyclin Analogs, Phosphodiesterase V…
Pulmonary Arterial Hypertension (PAH) Market by Key Players
Global Pulmonary Arterial Hypertension (PAH) Market: Snapshot
Pulmonary arterial hypertension (PAH) is a very rare type of progressive disorder related to high blood pressure. However, the rate of incidence of this disorder is gradually gaining traction. Various sources, including WHO and CDC, suggest that the global prevalence of PAH is anticipated to be between 100,000 and 200,000, narrowing down to about 15-50 cases per million heads. There is no permanent cure…